ZFP36L2 is a zinc finger CCCH-type RNA-binding protein that regulates gene expression post-transcriptionally by binding to adenine-uridine-rich elements (AREs) in the 3'-untranslated regions (3' UTRs) of target mRNAs 1. The protein destabilizes ARE-containing transcripts by recruiting the CCR4-NOT deadenylase complex and promoting poly(A) tail removal, thereby attenuating protein synthesis 1. ZFP36L2 functions as a 3'-UTR ARE adapter that communicates signaling events to the mRNA decay machinery 1. ZFP36L2 regulates multiple physiological processes including adipogenesis, neuron integrity, ovulation, and erythroid cell differentiation through ARE-mediated mRNA decay of functionally distinct targets 1. Critically, ZFP36L2 cooperates with ZFP36L1 to maintain B and T cell development by promoting decay of cell cycle regulators and the oncogenic NOTCH1 transcription factor, preventing T-cell acute lymphoblastic leukemia (T-ALL) transformation 2. Recent evidence reveals ZFP36L2's role in female reproduction: variants cause embryonic developmental arrest through disrupted mRNA stability affecting epigenetic marks 3. Additionally, ZFP36L2 functions as an innate immune defender against flavivirus infection via the 5'-3' XRN1-mediated RNA decay pathway in viral replication complexes 4. Dysregulation of ZFP36L2 expression associates with severe asthma pathogenesis 5 and predicts hepatocellular carcinoma recurrence risk 6.